Featured Research

from universities, journals, and other organizations

Hip And Knee Replacement Patients Not Receiving Treatment To Reduce Blood Clot Risk

Date:
June 2, 2008
Source:
McGill University Health Centre
Summary:
Fewer than 1 in 5 patients received post-discharge therapy to prevent life-threatening blood clots -- venous thrombosis -- after hip- or knee-replacement surgery, report Canadian researchers. Venous thrombosis is one of the leading causes of death among hospital patients. However, elderly patients have a 70% lower chance of dying within 3 months if they take an anticoagulant drug to prevent blood clots.

Fewer than 1 in 5 patients received post-discharge therapy to prevent life-threatening blood clots -- venous thrombosis -- after hip- or knee-replacement surgery, report Rahme and colleagues in a retrospective cohort study. Venous thrombosis is one of the leading causes of death among hospital patients. However, elderly patients have a 70% lower chance of dying within 3 months if they take an anticoagulant drug to prevent blood clots.

Hip and knee replacement surgery patients -- who are often elderly -- are at increased risk of developing potentially life-threatening thrombosis, or blood clots. Nevertheless, according to a study by Dr. Elham Rahme of the Research Institute of the McGill University Health Centre (RI-MUHC) and McGill University, most patients in Quebec do not receive the recommended treatment to prevent a thrombosis.

Dr. Rahme and her team analyzed the records of 7,058 Quebec hip and knee replacement patients, and discovered that only 19 percent of them received post-discharge antithrombotic treatment. The percentage varied somewhat between different hospitals and different lengths of hospital stay, but in almost all cases it remained well below official guidelines, which recommend at least 10 days, and up to 35 days, of treatment after surgery.

Although mortality risk following hip and knee replacement surgery is low, it increases for patients who do not receive antithrombotic treatment after leaving the hospital, the researchers said.

"This study is only the first step in a vast project on thrombosis related to hip and knee replacements. We have now determined the number of antithrombotic drug prescriptions in Quebec; our next step will consist in recruiting patients to analyze how well their prescribed antithrombotic treatments correspond to their medical conditions," Dr. Rahme explained.

It's unknown why antithrombotic drugs are so consistently underused, but concern about potential side-effects, particularly in the elderly, is one possibility. Nevertheless, the researchers said, this could not fully explain the huge gap between official treatment guidelines and the clinical realities revealed by this study.

The study will be published June 3 in the Canadian Medical Association Journal.

This study was supported by the Canadian Institutes of Health Research (CIHR).


Story Source:

The above story is based on materials provided by McGill University Health Centre. Note: Materials may be edited for content and length.


Cite This Page:

McGill University Health Centre. "Hip And Knee Replacement Patients Not Receiving Treatment To Reduce Blood Clot Risk." ScienceDaily. ScienceDaily, 2 June 2008. <www.sciencedaily.com/releases/2008/06/080602214301.htm>.
McGill University Health Centre. (2008, June 2). Hip And Knee Replacement Patients Not Receiving Treatment To Reduce Blood Clot Risk. ScienceDaily. Retrieved September 1, 2014 from www.sciencedaily.com/releases/2008/06/080602214301.htm
McGill University Health Centre. "Hip And Knee Replacement Patients Not Receiving Treatment To Reduce Blood Clot Risk." ScienceDaily. www.sciencedaily.com/releases/2008/06/080602214301.htm (accessed September 1, 2014).

Share This




More Health & Medicine News

Monday, September 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Get on Your Bike! London Cycling Popularity Soars Despite Danger

Get on Your Bike! London Cycling Popularity Soars Despite Danger

AFP (Sep. 1, 2014) Wedged between buses, lorries and cars, cycling in London isn't for the faint hearted. Nevertheless the number of people choosing to bike in the British capital has doubled over the past 15 years. Duration: 02:27 Video provided by AFP
Powered by NewsLook.com
We've Got Mites Living In Our Faces And So Do You

We've Got Mites Living In Our Faces And So Do You

Newsy (Aug. 30, 2014) A new study suggests 100 percent of adult humans (those over 18 years of age) have Demodex mites living in their faces. Video provided by Newsy
Powered by NewsLook.com
Liberia Continues Fight Against Ebola

Liberia Continues Fight Against Ebola

AFP (Aug. 30, 2014) Authorities in Liberia try to stem the spread of the Ebola epidemic by raising awareness and setting up sanitation units for people to wash their hands. Duration: 00:41 Video provided by AFP
Powered by NewsLook.com
California Passes 'yes-Means-Yes' Campus Sexual Assault Bill

California Passes 'yes-Means-Yes' Campus Sexual Assault Bill

Reuters - US Online Video (Aug. 30, 2014) California lawmakers pass a bill requiring universities to adopt "affirmative consent" language in their definitions of consensual sex, part of a nationwide drive to curb sexual assault on campuses. Linda So reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins